China Conjugate Vaccine Market Size, Trends, Growth & Outlook

China Conjugate Vaccine Market - By Product Type (Multivalent Conjugate Vaccines, Monovalent Conjugate Vaccines), By Disease Indication (Meningococcal, Pneumococcal, Influenza, Others), By Pathogen Type (Viral Conjugate Vaccine, Bacterial Conjugate Vaccine, Combination Conjugate Vaccine), By End User (Pediatrics, Adults) & China Region - Market Size, Trends, Opportunity, Forecast 2020-2028

Industry: Life Science | Report ID: FAMI-00519 | Published on: Oct, 2020 | View: 501 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

Facto Market Insights added a title on “China Conjugate Vaccine Market – 2020-2028” to its collection of market research reports. The study of the China conjugate vaccine market will include the analysis of all the comprehensive segments, along with the market size, Y-O-Y growth analysis and structure of the overall industry. The industry structure is based upon a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise. The regional manufacturers and new market players in the China conjugate vaccine market can also leverage the information which is available in the research report to make strategic business decisions in the industry.

The infectious coronavirus (formerly 2019-nCoV) broke out in late 2019, which has imposed a medical emergency across the globe. More than 175 countries and territories have reported cases of COVID-19. On March 11th, 2020, the WHO declared the novel coronavirus a pandemic officially. With the spread of these diseases, it is expected that the GDP of various developed & developing countries will decline in the upcoming years. Further, with the increasing instances of COVID-19 many countries went under lockdown situations to control the pandemic which is anticipated to hamper the growth of various industries. The report analyzes impact of COVID-19 on China conjugate vaccine market.

The study on the market research report also includes the section of market dynamics which defines the true prospect of the market. Further, the market dynamics section is segregated into market growth factors, market trends, market opportunities and market barriers which defines the current nature and future status of the China conjugate vaccine market. Along with this, the market research report also covers the facts & figures related to the macroeconomic trends that are expected to impact the growth of China conjugate vaccine market.

Additionally, the porter’s five forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the China conjugate vaccine market. In the market research report, the porter's five forces framework explains the method for analysing the competition of the business including industry structure and the level of competition in the overall market.

Moreover, the report also covers the section of competitive landscape of the China conjugate vaccine market, which includes the market share and positioning of all the major players in the industry. The competitive landscape analysis provides comprehensive analysis of the company’s business and performance including company overview, financial information of market players, business strategy, revenue breakup by segment and by geography, SWOT Analysis, key product offering, marketing and distribution strategies, new product development and recent news related with the market. The recent news section is further segregated into acquisition, expansion, technology development, research & development and other market activities.

China Conjugate Vaccine Market Segmentation:

The market for China conjugate vaccine is divided into five major segments which including product type, disease indication, pathogen type, end user and region. The study offers a comprehensive analysis of the segmentations in the China conjugate vaccine market, this segmentation includes the segments which hold the major contribution into the market and also provides detailed growth parameters about the market.

By Product Type

- Multivalent Conjugate Vaccines

- Monovalent Conjugate Vaccines

By Disease Indication         

- Meningococcal

- Pneumococcal

- Influenza

- Others

By Pathogen Type

- Viral Conjugate Vaccine

- Bacterial Conjugate Vaccine

- Combination Conjugate Vaccine

By End User

- Pediatrics

- Adults

By Geography

- China

China Conjugate Vaccine Market: Competitive Landscape

In the section of competitive landscape includes the market share analysis and positioning of the major & niche key players in the market. The market share analysis explains that how a firm is performing in the marketplace when it is compared to its competitors. In addition to this, the research report also includes the profiling of major & niche key players in the China conjugate vaccine market. Some of the key players profiled include:

  • GlaxoSmithKline
  • Pfizer Inc.
  • Merck & Co.
  • Novartis
  • Sanofi Pasteur
  • CSL Limited
  • Bharat Biotech International
  • Biological E Limited
  • Serum Institute of India


Timeline Considered for Analysis:

- 2019: Base Year

- 2020: Estimated Year

- 2020 to 2028: Forecast Period

Key Questions Answered in this Report:

  • What was the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2028?
  • What are the most promising and high-growth trends in the overall market?
  • What are the key factors impacting market dynamics? What are the growth drivers, and restraints in the China conjugate vaccine market?
  • What are the emerging industry trends in the China conjugate vaccine market?
  • What are recent development and advancement in the China conjugate vaccine market?
  • What merger & acquisition activities have occurred in the past 4 years and what is its impact on the market?

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in China Conjugate Vaccine Market
3. China Conjugate Vaccine Market Trends
4. Opportunities in China Conjugate Vaccine Market
5. Recent Industry Activities, 2020
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. China Conjugate Vaccine Market Size (USD Million), Growth Analysis and Forecast, (2020 - 2028)

9. China Conjugate Vaccine Market Segmentation Analysis, By Product Type
9.1. Introduction
9.2. Market Attractiveness, By Product Type
9.3. BPS Analysis, By Product Type
9.4. Multivalent Conjugate Vaccines
9.5. Monovalent Conjugate Vaccines

10. China Conjugate Vaccine Market Segmentation Analysis, By Disease Indication
10.1. Introduction
10.2. Market Attractiveness, By Disease Indication
10.3. BPS Analysis, By Disease Indication
10.4. Meningococcal
10.5. Pneumococcal
10.6. Influenza
10.7. Others

11. China Conjugate Vaccine Market Segmentation Analysis, By Pathogen Type
11.1. Introduction
11.2. Market Attractiveness, By Pathogen Type
11.3. BPS Analysis, By Pathogen Type
11.4. Viral Conjugate Vaccine
11.5. Bacterial Conjugate Vaccine
11.6. Combination Conjugate Vaccine

12. China Conjugate Vaccine Market Segmentation Analysis, By End User
12.1. Introduction
12.2. Market Attractiveness, By End User
12.3. BPS Analysis, By End User
12.4. Pediatrics
12.5. Adults

13. Geographical Analysis
13.1. Introduction
13.2. China Conjugate Vaccine Market Size (USD Million), 2020 - 2028
13.2.1. By Product Type
13.2.2. By Disease Indication
13.2.3. By Pathogen Type
13.2.4. By End User
13.2.5. By Country Market Attractiveness, By Country BPS Analysis, By Country China Market Size (USD Million), 2020 - 2028

14. Competitive Landscape
14.1. GlaxoSmithKline
14.2. Pfizer Inc.
14.3. Merck & Co.
14.4. Novartis
14.5. Sanofi Pasteur
14.6. CSL Limited
14.7. Bharat Biotech International
14.8. Biological E Limited
14.9. Serum Institute of India

Select License Type
  • Single User License $2550 USD
  • Multi-User License $3650 USD
  • Corporate User License $4750 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.